Select Page

Schneck Cancer Center is again sponsoring free Skin Cancer Screenings to be held July 23 at Schneck’s Cancer Center on the medical center campus. You must have a scheduled appointment to participate in the free screening and time slots are limited.
More than half of all new cancers are skin cancers and more than one million new cases of skin cancer will be diagnosed in the United States this year. In fact, 40 to 50 percent of Americans living to the age of 65 will develop skin cancer at least once in their lifetimes.
The screenings are by appointment only and will be conducted by Dr. Kevin M. Crawford, Advanced Dermatology and Cosmetic Surgery, LLC.
Dr. Crawford is a native of Indiana, graduating from Indiana University School of Medicine. He completed a family practice internship at Eglin Air Force Base and his dermatology residency at Emory University in Atlanta, Georgia. Currently, Dr. Crawford is an active-duty Captain in the United States Air Force and serves as Chief of Dermatology at Scott Air Force Base in Illinois.
According to Dr. Crawford, “The key to the successful treatment of most types of skin cancer is early detection. Skin cancer is cured in 85 to 95 percent of all cases; however, if detected early enough the cure rate could be near 100 percent. This is especially critical in the most deadly type of skin cancer, melanoma. Early detection of melanoma can literally be the difference between life and death. It is essential patients perform regular self skin checks and have routine exams by their dermatologist or primary care physician.”
Schneck Medical Center invites the public to take advantage of these free screenings. These screenings are not intended for diagnosis of rashes or other skin problems and should not be a replacement or substitution for regular visits to a physician.
To schedule a skin cancer screening, call Schneck’s Cancer Center at 812-522-0477. Leave your name and phone number and your call will be returned promptly. Again, screening times are limited so please call early.